Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trial

Meta-Analysis of Aspirin Versus Dual Antiplatelet Therapy Following Coronary Artery Bypass Grafting

(2018) Nayan Agarwal et al.   AMERICAN JOURNAL OF CARDIOLOGY

Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting

(2018) Qiang Zhao et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

2018 ESC/EACTS Guidelines on myocardial revascularization

(2018) Franz-Josef Neumann et al.   EUROPEAN HEART JOURNAL

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

(2018) Pascal Vranckx et al.   LANCET

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

(2017) Marco Valgimigli et al.   EUROPEAN HEART JOURNAL

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease

(2017) William R. Hiatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Thrombelastographic hypercoagulability and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): a randomized controlled trial

(2017) Sulman Rafiq et al.   PLATELETS

A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial

(2016) Antoinette de Waha et al.   AMERICAN HEART JOURNAL

Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack

(2016) S. Claiborne Johnston et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety of Preoperative Use of Ticagrelor With or Without Aspirin Compared With Aspirin Alone in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Grafting

(2016) Riccardo Gherli et al.   JAMA Cardiology

Ticagrelor: Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile: An Update

(2015) Renli Teng   CLINICAL PHARMACOKINETICS

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

(2015) Marco Roffi et al.   EUROPEAN HEART JOURNAL

Ticagrelor Crushed Tablets Administration in STEMI Patients

(2015) Guido Parodi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Dual antiplatelet therapy use by Canadian cardiac surgeons

(2015) Bobby Yanagawa et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials

(2015) Subodh Verma et al.   BMC Surgery

Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery

(2014) M. Sousa-Uva et al.   EUROPEAN HEART JOURNAL

Characterization of the Adenosine Pharmacology of Ticagrelor Reveals Therapeutically Relevant Inhibition of Equilibrative Nucleoside Transporter 1

(2014) Duncan Armstrong et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Adenosine-Mediated Effects of Ticagrelor

(2014) Marco Cattaneo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety

(2014) Paul P. Dobesh et al.   PHARMACOTHERAPY

2012 Update to The Society of Thoracic Surgeons Guideline on Use of Antiplatelet Drugs in Patients Having Cardiac and Noncardiac Operations

(2012) Victor A. Ferraris et al.   ANNALS OF THORACIC SURGERY

Aspirin plus clopidogrel for optimal platelet inhibition following off-pump coronary artery bypass surgery: results from the CRYSSA (prevention of Coronary arteRY bypaSS occlusion After off-pump procedures) randomised study

(2012) Vito Antonio Mannacio et al.   HEART

Mortality Benefit With Prasugrel in the TRITON–TIMI 38 Coronary Artery Bypass Grafting Cohort

(2012) Peter K. Smith et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Risk Stratification in the Setting of Non-ST Elevation Acute Coronary Syndromes 1999-2007

(2011) Isuru Ranasinghe et al.   AMERICAN JOURNAL OF CARDIOLOGY

Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial

(2011) Kenneth W. Mahaffey et al.   CIRCULATION

Antiplatelet agents for the treatment and prevention of atherothrombosis

(2011) Carlo Patrono et al.   EUROPEAN HEART JOURNAL

2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery

(2011) L. David Hillis et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction

(2011) Eric J. Velazquez et al.   NEW ENGLAND JOURNAL OF MEDICINE

Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study

(2010) Jack C.J. Sun et al.   AMERICAN HEART JOURNAL

Aspirin Plus Clopidogrel Versus Aspirin Alone After Coronary Artery Bypass Grafting

(2010) Alexander Kulik et al.   CIRCULATION

Aspirin Plus Clopidogrel Therapy Increases Early Venous Graft Patency After Coronary Artery Bypass Surgery

(2010) Ge Gao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery

(2010) Claes Held et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Mechanisms Potentially Contributing to the Reduction in Mortality Associated With Ticagrelor Therapy⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

(2010) David J. Schneider   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Impaired anti-platelet effect of aspirin, inflammation and platelet turnover in cardiac surgery☆☆☆

(2010) Hernán Cohen Arazi et al.   Interactive Cardiovascular and Thoracic Surgery

Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease

(2009) Paul A. Gurbel et al.   CIRCULATION

Ticagrelor — Is There Need for a New Player in the Antiplatelet-Therapy Field?

(2009) Albert Schömig   NEW ENGLAND JOURNAL OF MEDICINE

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

(2009) Lars Wallentin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease

(2009) Patrick W. Serruys et al.   NEW ENGLAND JOURNAL OF MEDICINE

Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent

(2008) Norbert Zimmermann et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY